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Abstract 
Background: Infectious diseases continue to be one of the biggest health challenges around the world, followed 
by problems caused by antibiotic resistance and excessive use of antibiotics. In general, Enterococcus faecalis 
is the main cause of nosocomial infections and is the most common cause of surgical ulcer infections. This 
study examines how a vancomycin nanomedicine attaches to poly lactic-co-glycolic acid (PLGA) nanoparticle. 
Determining the role of vancomycin nanomedicine on reducing the drug resistance of vancomycin in E. 
faecalis (clinical hospital isolates) and determining the cytotoxicity effects of nanomedicine. 
Materials and Methods: In this method, first, attachment made through chemical processes such as emulsion 
between vancomycin antibiotic and a PLGA nanoparticle, and resultant antibiotic tested on vancomycin 
resistant E. faecalis. 
Results: The results of this study indicate that the method of nanomedicine attachment to antibiotics was an 
effective method and it was determined by X-ray Diffraction that the attachment was precisely performed. In 
the antibiogram method, the minimum inhibitory concentration (MIC) and the minimum bactericidal 
concentration (MBC) of the nanomedicine increased in respect to vancomycin antibiotic.  
Conclusion: The results showed that produced Nano-antibiotics had a better effect than resistant antibiotics. 
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Introduction 
Infectious diseases continue to be one of the biggest 
health challenges throughout the world. Antibiotic 
resistance, excessive consumption of antibiotics in 
high-doses, high-costs and longtime needs to identify 




Vancomycin-resistance Enterococcus (VRE) is one of 
the most common pathogens in hospitals around the 
world. It was first observed in the 1980s (1986) in 
Europe and later in the United States. In the United 
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States, after the observation of the VRE, its 
prevalence increased dramatically in 1998, and the 
rate of hospital infection resulting from it between 
1989 and 1998 increased 20 times
3,4
. Excessive use 
of antibiotics (especially over the past 50 years) and 
the high capacity of Enterococcus for the acquisition 
and diffusion of antibiotic-resistance agents have 
made a serious problem in treatment of the related 
diseases. In Enterococcus, resistance to 
glycopeptides is a result of a gene cluster consisted 




Recently, unusual agents have been used to eliminate 
the drug resistance of some antibiotics. These agents 
are various classes of antimicrobial nanoparticles and 
carriers in the nanoscale for antibiotic delivery, 
which have been proven to be effective in laboratory 
samples and animal models
6,7
. Vancomycin resistant 
Enterococcus is one of the most common pathogens 
in the hospitals all over the world causing serious 
illnesses such as bacterial urogenital infections, 
endocarditis. One of the new drug therapy methods is 
drug delivery using nano-polymers such as 
nanoparticles
8,9
. These carriers are nanometer-size 
polymers. These carriers can enclose the drug inside 
them and thereby reduce its toxicity to the body. 
Meanwhile, these carriers increase the half-life of the 
drug in the body; therefore, a lower dosage of the 
drug will be needed for the treatment, which will in 
turn reduce the adverse effects of the drug in various 
tissues
4, 10
. The nanoparticles have unique properties. 
The application pattern of nanoparticles (NPs) or 
solid particles or dispersed particles is 10 to 1000 nm 
because of their small size and high reactivity 
5,11
. 
The aim of this study was to Examination of the 
Steps and attachment Circumstances of the Poly 
Lactic-co-glycolic Acid (PLGA) Nano-particle to 
increase the effect of Nanomedicine on Vancomycin-
resistant Enterococcus faecalis. 
Methods 
The ready-made PLGA nanoparticles were purchased 
from the Sigma Company. The PLA to PGA 
proportion in this experiment was same. 
First, 100 mg of PLGA dissolved in 1.3 and 0.7 ml 
Dichloromethane- acetone. Vancomycin was added 
to the nanoparticle and Dichloromethane solution on 
a magnetic rotator. The solution called as an initial 
water/oil emulsion. The resulting emulsion was 
sonicated in three steps, each for 10 seconds and 4 ml 
of polyvinyl alcohol 1% solution was added to this 
initial emulsion. This emulsion was also sonicated 
three times as the previous step. After sonication, 4 ml 
of polyvinyl alcohol 0.5% was added to this secondary 
emulsion. Then, for three hours, in order to evaporate 
the Dichloromethane, it was placed on a magnetic 
rotator (all steps were done on ice). The particles were 
centrifuged for 40 minutes at 16000 rpm. After 
removal of the supernatant, the resulted sediment was 
washed with 10 ml of distilled water in three steps, 
and the nanoparticles were dried by lyophilization. 
The PLGA Nano Capsules containing the drug, until 
the microbial steps, were stored in -20° freezer
19
. 
The method of measuring the minimum inhibitor 
concentrations (MIC) by microbroth method was 
determined using the Mueller Hinton growth medium 
and antibiotic powders and McFarland Suspension 0.5, 
in accordance with the International Committee of 
Clinical Laboratory Standards Committee (NCCLS). 
The minimum inhibitor concentration was determined 
based on the CLSI method and the lowest 
concentration of antibiotic that inhibited the growth of 
the bacterium was recorded as MIC (Negative control 
was bacteria suspension with antibiotic and positive 
control was bacteria suspension without antibiotic). 
Results 
The information related to each material existed in the 
X-ray device, and the name of the material could be 
declared according to the spectrum obtained. In this 
case, the PLGA nanomedicine attached to vancomycin 
was a new material therefore the device could not 
detect it. In the spectrum 1, vancomycin antibiotic 
peaks are observed. 
When a PLGA nanoparticle attaches to a vancomycin, 
new peaks were created, previous peaks disappeared, 
and in some cases, peak intensity was varies. In cases 
where the preceding material did not disappear, 
remaining some of the peaks indicated that some of 
the PLGA nanoparticles had not been attached to the 
vancomycin. Various peaks in spectrum 3 represented 
the attachment.  
As the results of MIC and the minimum bactericidal 
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concentration (MBC), the effect of produced 
nanoparticles and the vancomycin in various 
concentrations on vancomycin-resistant E. faecalis 
has been shown. In this study, MIC was 64μg/ml in 
the presence of vancomycin and was 16μg/ml in the 
presence of the vancomycin PLGA nanoparticle. 
Discussion 
Despite the widespread application of antibiotics 
especially Penicillin and the detection of novel anti-
microbial factors, Enterococcus remain the prevalent 
head of hospital infections especially in ICU
12,13
. The 
Enterococcusu may create meningitis and bacteremia 
among children and endocarditis among adults. A 
primary problem in facing with the Enterococcus is 




In the recent research, the PLGA (PLA⁄PGA=50⁄50) 
nanoparticle was used for encapsulating vancomycin. 
After conducting experiment steps, the effect of 
encapsulation process and effects of particles on each 
other through X-ray diffraction (XRD) device 
investigated. 
The results showed that the vancomycin antibiotic 
successfully was attached to the PLGA nanoparticle 
and decreased the amount of MIC and MBC E. 
faecalis in the presence of vancomycin than the 
vancomycin antibiotic which indicates the 
effectiveness of this method
 15,16
. 
Ansari et al. (2014) separated curcumin from 
turmeric and synthesized with poly lactic-co-glycolic 
acid nanoparticle. Due to the antibacterial effects of 
curcumin, this material is changes into a nano form 
and analyzed its effects on methicillin-resistant stuff. It 
was stated in this study that PLGA covers the intended 
drug and free a constant amount of drug by means of 
emission in polymer and polymer matrix degradation. 
Meanwhile, this nanoparticle is a proper carrier of 
delivering the drug to the target cell; and these 
nanoparticles can be prescribed into capillaries 
systematically and without accumulation problem
17
. 
Afsharnejad et al. (2012) studied on cyanoacrylate 
composite for dental applications and conducted the 
cell toxicity test on L929 cell lines through MTT 
method. In 24-hour and 48-hour tests, more than 70% 
of cells survived. However, the 30% cells survived 
after 72 hours by neighboring the nanocomposite on 
the L929 cells. The lower the amount of concentration 
of this nanocomposite, the lower amount of cell 
 








Spectrum 2. XRD of PLGA Nano Particle. 
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Yang et al. (2014) studied on the PLGA 
nanoparticles that possess significant absorption and 
were little molecules with low potential. By means of 
this nanoparticle, a drug was created with low 
solubility and permeability into the cell although it 
increases the negative load of cell surface. Recently, 
PLGA-NPs oral nanomedicine has been created that 
in this research the aim was introduction and 
evaluation of the physio-chemistry of above-
mentioned nanomedicine, which has covered the 
positive load of chitosan. The thein orphan as a 
medicine was added to the model. Ca-Co-2 was also 
added to the above-mentioned nanomedicine, which 
significantly increases the cell absorption. The 
disease is about smart and targeted medicines
19
. 
Stevanovic et al. (2013) used PLGA nanomedicines, 
silver and ascorbic acid in order to evaluate the effect 
of these nanoparticles on the positive and negative 
gram bacteria, E. coli and penicillin-resistant 
Staphylococcus aureus, which created a nanoparticle 
by this material; and analyzed it according to 
morphology and osteogenic markers’ expression on 
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